Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes

To achieve the 90-90-90 goals set by UNAIDS, the number of new HIV infections needs to decrease to approximately 500,000 by 2020. One of the ‘five pillars’ to achieve this goal is pre-exposure prophylaxis (PrEP). Truvada (emtricitabine-tenofovir) is currently the only medication approved for PrEP. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Duwal, Sulav, Dickinson, Laura, Khoo, Saye, von Kleist, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001963/
https://www.ncbi.nlm.nih.gov/pubmed/29902179
http://dx.doi.org/10.1371/journal.pcbi.1006155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001963/
https://www.ncbi.nlm.nih.gov/pubmed/29902179
http://dx.doi.org/10.1371/journal.pcbi.1006155

Ejemplares similares